Metavention Announces Initiation of Groundbreaking Multi-Organ Denervation Study

Metavention Announces Initiation of Groundbreaking Multi-Organ Denervation Study

MINNEAPOLIS, May 4, 2021 /PRNewswire/ -- Metavention, Inc. announces the initiation of the MODUS Study (ACTRN12620000412932), to treat patients with both type 2 diabetes and hypertension using a catheter-based, minimally invasive approach.

The first procedures in this study were successfully completed at The Alfred Hospital in Melbourne, Australia b...

Read more: Metavention Announces Initiation of Groundbreaking Multi-Organ Denervation Study

More Articles …

  1. New members elected to Occlutech Board of Directors
  2. Hi-Chew Rolls Out New Website in Australia and New Zealand to Support Major Retail Expansion
  3. Dubber March 2021 Quarterly Activities and Business Update
  4. 106 MW BayWa r.e. solar farm now supplying green energy to Northern Victoria
  5. New Natural Wellness Podcast Rounds Up All Blacks Manager and Other Experts to Share Tips for Optimal Health
  6. Eka Unveils E-Sourcing, a cloud-based source-to-pay solution to drive a new era of digitalization in supplier management
  7. Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report
  8. Vectra AI Raises $130 Million led by Blackstone Growth (BXG)
  9. 2021, a turning point for PQE Group: no more internal hierarchy and a hiring plan of 550 new employees
  10. Virgin Money partners with Fintech Trade Ledger as part of a new business banking proposition